Please try another search
Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Johan Lindh | - | - | Director |
Bert Junno | 57 | 2020 | Co-Founder & Chairman of the Board |
Anders Bylock | - | 2016 | Chairman of the Scientific Advisory Board |
Theresa Comiskey Olsen | 60 | 2020 | Director |
Christina Glad | 71 | 2016 | Director |
Mats Eriksson | - | - | Member of Scientific Advisory Board |
Asa Kornfeld | - | 2022 | Director |
Jan Nilsson | 74 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review